Press Release: InDevR expands commercialization team to meet market demand.

Press Release: InDevR co-founders Laura Kuck, John Birks and Kathy Rowlen sponsor educational fellowships at Front Range Community College.

Press Release: InDevR Inc. launches breakthrough colorimetric detection for microarrays using core technology from CU.

InDevR introduces ampliPHOX, a breakthrough technology for low-density microarrays, with a limited time offer.

InDevR selected to receive a Colorado Export Development Grant from the Office of Economic Development and International Trade.

K. Rowlen, InDevR’s CEO, a keynote speaker at the Western Regional Center of Excellence for Biodefense and Emerging Infectious Diseases Research.

InDevR scientists publish paper in Bioprocess International highlighting correlation between Virus Counter and quantitative RT-PCR for the quantification of influenza virus.

InDevR’s CEO Kathy Rowlen was a guest speaker on the Biotech Panel of the Boulder Economic Summit, May 18th, 2011.

InDevR’s CEO Kathy Rowlen was a key participant at Boulder’s Startup America: Reducing Barriers, May 9th 2011.

InDevR’s CEO, Kathy Rowlen, was a featured presenter at the 2011 Biobootcamp: Building life science businesses, April 15, 2011 in Denver, CO.

InDevR’s Erica Dawson was the featured guest speaker at CIRES’ Analytical Chemistry Seminar, March 28, 2011 at the Univserity of Colorado, Boulder.

Press Release: InDevR Inc. receives a $3 million, three-year grant from the National Institutes of Health.

Press Release: InDevR Signs Global Distributors and will market the Virus Counter to scientists in India, China, Japan, Korea, Belgium, Luxembourg, the Netherlands, the United Kingdom and the United States.

Press Release: A study published in the January issue of Journal of Virological Methods demonstrates InDevR’s Virus Counter effectiveness.

Press Release: Applikon Biotechnology Announces an Agreement With InDevR to Distribute the ViroCyt®Virus Counter®.

Press Release: InDevR recently appointed Amy Whittier as its director of sales and marketing and Michael Minard as its director of business development.

InDevR’s Virus Counter featured in Genetic Engineering & Biotechnology News:
New Method for Rapid Virus Quantification.

InDevR Featured in Schott’s Microarray Solutions Newsletter: Low-Density Microarrays with ampliPHOX™ Colorimetric Detection based on Nexterion® Slide AL.

InDevR is proud to announce a new model Virus Counter®. The ViroCyt® 2100 is CE certified and offers additional data handling capabilities as well as new software features relative to the ViroCyt 1100. For more information, contact sales@indevr.com.

Press Release: Free Trial Offer: ampliPHOX Colorimetric Detection Technology for Low-Density Microarrays.

InDevR’s ampliPHOX Colorimetric Detection Technology, currently in beta testing with a collaborator, USDA/ARS/WRRC, Produce Safety and Microbiology Research Unit in Albany, CA., was highlighted at the recent American Society for Microbiology National Meeting. A poster detailing work on E. coli detection using ampliPHOX Detection Technology was presented and well received. The presentation was entitled: “Use of photopolymerization for the rapid and cost-effective identification of Shiga toxin-producing Escherichia coli on DNA microarrays”.

InDevR receives a 2010 “Colorado Companies to Watch” award. The award selection process is organized by the Colorado Office of Economic Development and International Trade. The awards ceremony is to be held on June 18th, 2010 at the Denver Marriott City Center.

Press Release: InDevR to Collaborate with Scientists at the CDC to Develop New Influenza Virus Surveillance Assay.

Press Release: InDevR and Sales Partnerships Inc. Announce Strategic Alliance for InDevR’s Virus Counter Product Line.

Press Release: InDevR’s ampliPHOX colormetric detection technology in beta site-testing.

InDevR authors a book chapter entitled:
MChip: a Single Gene Diagnostic Microarray for Influenza A
Influenza: Molecular Virology, February 2010, by Erica D. Dawson and Kathy L. Rowlen.

InDevR named Boulder’s SBDC “Client of the Year”

Press Release: InDevR’s Virus Counter^® to Streamline Vaccine Development.

InDevR sponsors the GO3 Project
(Global Ozone Project) for Students, Teachers, and Scientists.

InDevR receives BioScience Discovery Grant from the State of Colorado to commercialize ampliPHOX™ detection technology.

Press Release: InDevR’s FluChipM6 detects and distinguishes swine-origin H1N1 from seasonal influenza viruses.

Press Release: InDevR licenses the FluChip technology from the University of Colorado. The FluChip was invented by a joint team of scientists at the University of Colorado and the Centers for Disease Control and Prevention in an NIH-sponsored effort led by Professor Kathy Rowlen. Watch related video story broadcast on CBS Denver Channel 4.

InDevR goes “green” and initiates extensive recycling/composting program.

InDevR expands its facilities from 2,500 to 6,000 sq. ft.

InDevR receives NIH SBIR Phase II Grant for Virus Counter® development.

2B Technologies receives ISO 9000:2001 certification. View the certificate.

InDevR converts from LLC to Corporation.

Co-Founder Dr. Kathy Rowlen receives University of Colorado, Boulder “Inventor of the Year” Award sponsored by Faegre & Benson.

InDevR acquires majority stock in 2B Technologies, Inc.